Search for: "RANBAXY INC" Results 61 - 80 of 93
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
3 Mar 2012, 9:45 am by Lawrence B. Ebert
In an article titled Sector Snap: Generic competition and biotech drugs , one notes the irony that generic maker Teva is facing Hatch-Waxman challenges from Mylan Inc. and Novartis AG over its patented drug Copaxone, a drug for treatment of multiple sclerosis. [read post]
1 Dec 2011, 3:58 am by Lawrence B. Ebert
Yes, Virginia, Ranbaxy Will Sell A Generic Lipitor Ranbaxy to Share Part of Lipitor Profits With Teva**UPDATE. [read post]
30 Jun 2011, 9:18 pm by Aaron Barkoff
Munsingwear, Inc. that hold that courts should vacate judgments in a case that becomes moot unless the moving party's actions make vacatur inequitable.   [read post]
26 Apr 2011, 11:15 pm
Ranbaxy Laboratories manufactured an Accutane version called Sotret which has been withdrawn. [read post]
13 Apr 2011, 5:13 pm by FDABlog HPM
District Court for the District of Arizona (Phoenix Division) against Eisai, Inc. and Eisai Medical Research, Inc. [read post]
11 Oct 2010, 12:59 pm by FDABlog HPM
Brooks Brothers, Inc. in which the Court addressed standing under 35 U.S.C. § 292.  [read post]
8 Aug 2010, 8:32 pm by Patent Docs
Ranbaxy Laboratories Ltd. et al. 2:10-cv-03897; filed August 4, 2010 in the Eastern District of Pennsylvania • Plaintiff: Lupin Atlantis Holdings S.A. • Defendants: Ranbaxy Laboratories Ltd.; Ranbaxy Pharmaceuticals Inc.; Ranbaxy, Inc.; Ethypharm S.A. [read post]
16 Jul 2010, 7:14 am by The Docket Navigator
Ranbaxy Laboratories Inc., 2-10-cv-00121 (TXED July 14, 2010, Report & Recommendations) (Everingham, M.J.) [read post]